4 ms·
FDA Approves Drug with New Mechanism of Action for Treatment of Schizophrenia
- reify 2y agonot developed out of altruism or care for those struggling with schizophrenia. In 2024, Bristol Myers Squibb purchased the drug from Karuna for US$14 billion. Bristol Myers Squibb set the wholesale cost of the combo at $1,850 a month. The effectiveness of xanomeline/trospium chloride for the treatment of schizophrenia in adults was evaluated in two studies with identical designs. Study 1 and study 2 were 5-week, randomized, double-blind, placebo-controlled, multi-center studies in adults with a diagnosis of schizophrenia according to DSM-5 criteria. I am fully aware that all antipsychotics are basically chemical coshes and there is no evidence that they actually work to cure psychiatric illnesses in the long term.